Systemic and mucosal antibody secretion specific to SARS-CoV-2 during mild versus severe COVID-19
C. Cervia, J. Nilsson, Y. Zurbuchen, A. Valaperti, J. Schreiner, A. Wolfensberger, M. E. Raeber, S. Adamo, M. Emmenegger, S. Hasler, P. P. Bosshard, E. De Cecco, E. Baechli, A. Rudiger, M. Stuessi-Helbling, , O. Boyman
This study compares SARS-CoV-2-specific antibody responses in mild and severe COVID-19 patients and healthcare workers, finding higher systemic IgA and IgG in severe cases and mucosal IgA in asymptomatic exposed individuals.
bioRxiv · May 21, 2020Immunology